ReviewGels (Basel, Switzerland)2026
Recent Progress and Morphological Distribution of Polydopamine-Based Biomaterials and Their Applications.
Review in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polydopamine (PDA) is a bioinspired polymer known for its strong adhesiveness, biocompatibility, and functional properties, making it highly useful in biomedical applications. This review highlights recent progress in PDA-based biomaterials, with a focus on their morphology, synthesis techniques, and various biomedical uses. It examines how PDA composites, which are formed at the nanoscale and macroscale levels, contribute to drug delivery, tissue engineering, wound healing, and cancer treatment. The ability of PDA to create stable, functional coatings and composites that bond well with different biomaterials enhances its therapeutic potential. This review also discusses challenges such as structural stability, toxicity, and production scale. Additionally, it covers different polymerization mechanisms and their implications for future clinical use. With ongoing advancements, PDA-based materials hold great promise for personalized medicine, including targeted drug delivery, photothermal therapy, and tissue regeneration. Overall, this overview emphasizes the vital role of PDA in the progression of biomedical technology and its potential for future applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.